Canada markets open in 36 minutes

Algernon Pharmaceuticals Inc. (AGN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1150+0.0100 (+9.52%)
At close: 09:37AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 2.49M
Enterprise Value 2.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.46
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.63

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-54.00%
S&P500 52-Week Change 323.57%
52 Week High 30.2650
52 Week Low 30.0000
50-Day Moving Average 30.0973
200-Day Moving Average 30.1088

Share Statistics

Avg Vol (3 month) 327.58k
Avg Vol (10 day) 326.18k
Shares Outstanding 521.64M
Implied Shares Outstanding 621.64M
Float 814.26M
% Held by Insiders 10.81%
% Held by Institutions 113.88%
Shares Short (Mar 15, 2024) 417.13k
Short Ratio (Mar 15, 2024) 40.03
Short % of Float (Mar 15, 2024) 4N/A
Short % of Shares Outstanding (Mar 15, 2024) 40.00%
Shares Short (prior month Feb 15, 2024) 4464

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 24:1
Last Split Date 3Mar 03, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 31, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.77%
Return on Equity (ttm)-257.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.46M
Net Income Avi to Common (ttm)-5.18M
Diluted EPS (ttm)-0.2800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)76.28k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.04
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-1.6M
Levered Free Cash Flow (ttm)-432.31k